-
[Latest] Global Lung Tumor Market Size/Share Worth USD 46.3 Billion by 2033 at a 7.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15 Apr 2024 16:30 GMT
… lung tumor diagnosis. This delay could result in the diagnosis of lung tumors … Related Reports: Lung Cancer Liquid Biopsy Market: Lung Cancer Liquid Biopsy … (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), …
-
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
22 Feb 2024 14:19 GMT
… lung cancer, precision oncology has achieved notable advances. Lung cancer … ; Genentech), trastuzumab (Herceptin; Genentech), T-DM1 … Lung Cancer: From Broad Treatment to Individualized Approaches
Lung cancer … Immunotherapy in lung cancer. Transl Lung Cancer Res. …
-
Lung Cancer Surgery Market Worth USD 7.8 billion by 2030, Trends Analysis, Growth Rate, Share, Size, Revenue, Opportunities, Challenges, Key Drivers, Instrument, Procedure, Volume Data, Forecasts 2023-2030 | Exclusive Report by Delvens
15 May 2023 14:35 GMT
… of diagnosing and treating lung cancer Therapies for lung cancer can be broadly categorised … ;CAS9, Others), Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade …
-
Indian oncology landscape has room for improvement in cancer detection rates: Dr Neil Iyengar
16 Apr 2024 10:24 GMT
… breast cancer, prostate cancer, and lung cancer. We recognize the need to … limited treatment options, such as Herceptin for HER2-positive breast cancer …
-
Boryung's licensed-in lung cancer drug wins approval in Korea
27 Sep 2022 04:43 GMT
… : lurbinectedin), a small cell lung cancer (SCLC) drug licensed-in … for Zepzelca, a small cell lung cancer (SCLC) drug.
Under … faster than non-small cell lung cancer (NSCLC). SCLC also … and Samfenet, a biosimilar referencing Herceptin, in December.
This year …
-
FDA grants Enhertu accelerated approval for HER2-mutated non-small cell lung cancer
12 Aug 2022 21:21 GMT
… metastatic non-small cell lung cancer.
The approval applies … acid sequence as trastuzumab (Herceptin, Genentech); a topoisomerase … metastatic non-small cell lung cancer (press release). Available … -Metastatic-Non-Small-Cell-Lung-Cancer. Published Aug. 11, …
-
Precision Diagnostics Can Save Money In Healthcare: What’s Holding Them Back?
09 Apr 2024 02:01 GMT
… example, breast cancer patients taking Herceptin (trastuzumab) must be HER2-positive … that prior to being prescribed Herceptin they undergo diagnostic testing to … receptor 2.
Non-small cell lung cancer can also be differentially treated …
-
US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors
05 Apr 2024 21:49 GMT
… breast cancer, gastric cancer and lung cancer. Enhertu belongs to a class … case trastuzumab (also known as Herceptin) - chemically linked to a …
-
Samsung Biopeis’ Keytruda biosimilar enters Phase III trials
05 Apr 2024 19:24 GMT
… non-squamous non-small cell lung cancer (NSCLC). Efficacy, safety, pharmacokinetics, and … Enbrel (etanercept) and Genentech’s Herceptin (trastuzumab), amongst others.
Samsung Bioepis …
-
Opinion: Personalized medicine: We’re not there yet
05 Apr 2024 12:53 GMT
… did provide proofs of principle.
Herceptin (trastuzumab), Iressa (gefitinib), and Gleevec … with advanced non-small cell lung cancer who may have benefitted from …